SG
ELV icon

Swarthmore Group’s Elevance Health ELV Stock Holding History

Swarthmore Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$311K Sell
644
-13,881
-96% -$6.87M 0.13% 23
2022
Q1 		$7.13M Sell
14,525
-155
-1% -$70.9K 1.82% 10
2021
Q4 		$6.8M Sell
14,680
-14,557
-50% -$6.12M 1.62% 23
2021
Q3 		$11.2M Hold
29,237
– – 2.88% 6
2021
Q2 		$11.2M Sell
29,237
-865
-3% -$331K 2.88% 6
2021
Q1 		$10.8M Buy
30,102
+27,709
+1,158% +$8.91M 2.95% 8
2020
Q4 		$768K Sell
2,393
-27,930
-92% -$8.57M 2.93% 14
2020
Q3 		$8.14M Buy
30,323
+1,201
+4% +$323K 2.56% 14
2020
Q2 		$7.66M Buy
29,122
+26,729
+1,117% +$7.13M 2.61% 12
2020
Q1 		$543K Sell
2,393
-28,182
-92% -$7.68M 2.88% 14
2019
Q4 		$9.23M Sell
30,575
-650
-2% -$179K 2.14% 8
2019
Q3 		$7.5M Sell
31,225
-825
-3% -$226K 1.85% 19
2019
Q2 		$9.04M Buy
32,050
+28,750
+871% +$7.85M 2.23% 10
2019
Q1 		$947K Sell
3,300
-36,450
-92% -$10.5M 4.07% 6
2018
Q4 		$10.4M Sell
39,750
-3,000
-7% -$825K 2.72% 7
2018
Q3 		$11.7M Sell
42,750
-300
-0.7% -$77.9K 2.63% 6
2018
Q2 		$10.2M Sell
43,050
-4,000
-9% -$926K 2.47% 9
2018
Q1 		$10.3M Sell
47,050
-6,700
-12% -$1.57M 2.46% 7
2017
Q4 		$12.1M Hold
53,750
– – 2.58% 6
2017
Q3 		$10.2M Sell
53,750
-9,400
-15% -$1.79M 2.33% 9
2017
Q2 		$11.9M Sell
63,150
-48,250
-43% -$8.67M 2.74% 9
2017
Q1 		$18.4M Buy
+111,400
New +$17.7M 2.83% 11

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Swarthmore Group's ELV Position: Q2 2022 in Review

Swarthmore Group reduced its Elevance Health (ELV) stake by 96% in Q2 2022, selling an estimated $6.87M and leaving 644 shares worth $311K. The position accounts for 0.13% of the portfolio, ranked #23.

Swarthmore Group first reported a position in ELV in Q1 2017 and has held it in 22 quarters since. The position peaked at $18.4M in Q1 2017. 1,440 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

  • Swarthmore Group held 644 shares of Elevance Health worth $311K as of Q2 2022.
  • Swarthmore Group sold 13,881 Elevance Health shares in Q2 2022, an estimated $6.87M.
  • Elevance Health made up 0.13% of Swarthmore Group's portfolio in Q2 2022, its #23 holding.
  • Swarthmore Group first reported a position in Elevance Health in Q1 2017 and has held it in 22 quarters since.
  • Swarthmore Group's Elevance Health position peaked at $18.4M in Q1 2017.
  • 1,440 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Swarthmore Group's 13F filing for Q2 2022, filed 20 Jul 2022.